H. B. Fuller (NYSE:FUL) Given New $62.00 Price Target at Citigroup

H. B. Fuller (NYSE:FUL) had its target price cut by Citigroup from $70.00 to $62.00 in a research report sent to investors on Friday morning, MarketBeat reports. They currently have a neutral rating on the specialty chemicals company’s stock.

Other analysts have also recently issued reports about the company. Robert W. Baird upped their price objective on H. B. Fuller from $60.00 to $75.00 and gave the stock an “outperform” rating in a report on Friday, June 27th. JPMorgan Chase & Co. upped their price objective on H. B. Fuller from $50.00 to $54.00 and gave the stock an “underweight” rating in a report on Friday, June 27th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, H. B. Fuller has a consensus rating of “Hold” and a consensus target price of $65.75.

H. B. Fuller Price Performance

FUL stock opened at $58.15 on Friday. H. B. Fuller has a one year low of $47.56 and a one year high of $81.69. The company’s fifty day moving average price is $59.67 and its 200-day moving average price is $57.22. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.15 and a current ratio of 1.93. The company has a market capitalization of $3.14 billion, a PE ratio of 27.82, a price-to-earnings-growth ratio of 0.95 and a beta of 1.14.

H. B. Fuller (NYSE:FUL) last released its earnings results on Wednesday, September 24th. The specialty chemicals company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.24 by $0.02. H. B. Fuller had a net margin of 3.28% and a return on equity of 11.49%. The firm had revenue of $892.04 million for the quarter, compared to the consensus estimate of $894.60 million. During the same quarter in the previous year, the firm earned $1.13 earnings per share. The company’s quarterly revenue was down 2.8% compared to the same quarter last year. H. B. Fuller has set its FY 2025 guidance at 4.100-4.250 EPS. On average, equities analysts anticipate that H. B. Fuller will post 4.07 EPS for the current fiscal year.

H. B. Fuller Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, August 14th. Investors of record on Thursday, July 31st were issued a dividend of $0.235 per share. This represents a $0.94 annualized dividend and a yield of 1.6%. The ex-dividend date was Thursday, July 31st. H. B. Fuller’s dividend payout ratio is presently 50.81%.

Insider Buying and Selling at H. B. Fuller

In related news, VP Joao Magalhaes sold 1,099 shares of the stock in a transaction on Friday, August 8th. The stock was sold at an average price of $56.31, for a total transaction of $61,884.69. Following the sale, the vice president owned 3,285 shares in the company, valued at approximately $184,978.35. This represents a 25.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Robert J. Martsching sold 9,546 shares of the stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $64.30, for a total value of $613,807.80. Following the completion of the sale, the vice president owned 14,980 shares in the company, valued at approximately $963,214. The trade was a 38.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,691 shares of company stock worth $734,478 in the last 90 days. 1.99% of the stock is currently owned by insiders.

Institutional Trading of H. B. Fuller

Hedge funds and other institutional investors have recently bought and sold shares of the business. Parallel Advisors LLC increased its stake in H. B. Fuller by 141.6% in the second quarter. Parallel Advisors LLC now owns 534 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 313 shares during the period. EverSource Wealth Advisors LLC increased its stake in H. B. Fuller by 129.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock worth $73,000 after purchasing an additional 688 shares during the period. Smartleaf Asset Management LLC increased its stake in H. B. Fuller by 44.4% in the second quarter. Smartleaf Asset Management LLC now owns 1,307 shares of the specialty chemicals company’s stock worth $81,000 after purchasing an additional 402 shares during the period. Signaturefd LLC increased its stake in H. B. Fuller by 20.5% in the second quarter. Signaturefd LLC now owns 1,743 shares of the specialty chemicals company’s stock worth $105,000 after purchasing an additional 297 shares during the period. Finally, Strs Ohio purchased a new stake in H. B. Fuller in the first quarter worth $101,000. Hedge funds and other institutional investors own 95.93% of the company’s stock.

About H. B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.